APA citiranje

Fernandez, M. L., Dawson, A., Hoenisch, J., Kim, H., Bamford, S., Salamanca, C., . . . Carey, M. S. (2019). Markers of MEK inhibitor resistance in low-grade serous ovarian cancer: EGFR is a potential therapeutic target. Cancer Cell Int.

Citação norma Chicago

Fernandez, Marta Llaurado, et al. "Markers of MEK Inhibitor Resistance in Low-grade Serous Ovarian Cancer: EGFR Is a Potential Therapeutic Target." Cancer Cell Int 2019.

MLA citiranje

Fernandez, Marta Llaurado, et al. "Markers of MEK Inhibitor Resistance in Low-grade Serous Ovarian Cancer: EGFR Is a Potential Therapeutic Target." Cancer Cell Int 2019.